Browse by Glasgow Author

V体育官网入口 - 2012

Mutrie, N., "V体育官网" Campbell, A., "V体育安卓版" Barry, S. ORCID: https://orcid.org/0000-0003-3039-8729, Hefferon, K., McConnachie, A. ORCID: https://orcid.org/0000-0002-7262-7000, "VSports注册入口" Ritchie, D. and Tovey, S. (2012) Five-year follow-up of participants in a randomised controlled trial showing benefits from exercise for breast cancer survivors during adjuvant treatment. Are there lasting effects? Journal of Cancer Survivorship Research and Practice, 6(4), pp. 420-430. (doi: 10.1007/s11764-012-0233-y)

2009

VSports app下载 - Tovey, S.M., Brown, S.B., Doughty, J.C., Mallon, E.A., Cooke, T.G. and V体育ios版 - Edwards, J. (2009) Poor survival outcomes in HER2 positive breast cancer patients with low grade, node negative tumours. British Journal of Cancer, 100(5), pp. 680-683. (doi: 10.1038/sj.bjc.6604940)

2008

Kirkegaard, T., Naresh, A., Sabine, V.S., Tovey, S.M., Edwards, J., "VSports在线直播" Dunne, B., Cooke, T.G., Jones, F.E. (V体育官网) and Bartlett, J.M.S. (2008) Expression of tumor necrosis factor [alpha] converting enzyme in endocrine cancers. American Journal of Clinical Pathology, 129, pp. 735-743. (doi: 10.1309/N6YB6YDVF58YCNHN)

Campbell, E. J. , McDuff, E. , Tatarov, O. , Tovey, S. , Brunton, V. G. , Cooke, T VSports手机版. G. and Edwards, J. (2008) Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer. British Journal of Cancer, 99(11), pp. 1769-1774. (doi: 10. 1038/sj. bjc. 6604768) .

Kirkegaard, T. et al. (2008) Genetic alterations of CCND1 and EMSY in breast cancers. Histopathology, 52(6), pp V体育安卓版. 698-705. .

2007 (VSports app下载)

"V体育ios版" Cannings, E, Kirkegaard, T, "VSports" Tovey, SM, Dunne, B, VSports app下载 - Cooke, TG and V体育官网 - Bartlett, JMS (2007) Bad expression predicts outcome in patients treated with tamoxifen. Breast Cancer Research and Treatment, 102, pp. 173-179. (doi: 10.1007/s10549-006-9323-8)

"VSports手机版" Kirkegaard, T. , McGlynn, L. M. , Campbell, F VSports最新版本. M. , Muller, S. , Tovey, S. M. , Dunne, B. , Nielsen, K. V. (VSports注册入口), Cooke, T. G. and Bartlett, J. M. (2007) Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients. Clinical Cancer Research, 13(5), pp. 1405-1411. (doi: 10. 1158/1078-0432. CCR-06-1933) .

2006

VSports app下载 - Naresh, A, Long, WW, V体育平台登录 - Vidal, GA, Wimley, WC, Marrero, L, Sartor, CI, Tovey, S, Cooke, TG, Bartlett, JMS and Jones, FE (2006) The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells. Cancer Research, 66, pp. 6412-6420. (doi: 10.1158/0008-5472.CAN-05-2368)

Tovey, S. M. , Dunne, B. (V体育2025版), Witton, C. J. , "V体育2025版" Cooke, T. G. and Bartlett, J VSports注册入口. M. S. (2006) HER4 in breast cancer: comparison of antibodies against intra- and extra-cellular domains of HER4. Breast Cancer Research, 8, (doi: 10. 1186/bcr1394) .

Tovey, SM, Reeves, JR, Stanton, P, V体育ios版 - Ozanne, BW, VSports app下载 - Bartlett, JMS and Cooke, TG (2006) Low expression of HER2 protein in breast cancer is biologically significant. Journal of Pathology, 210(3), pp V体育官网入口. 358-362. (doi: 10. 1002/path. 2057) .

2005

Kirkegaard, T. , Witton, C. J. , McGlynn, L. M. , Tovey, S. M. (V体育ios版), Dunne, B. , Lyon, A. and Bartlett, J. M. (2005) AKT activation predicts outcome in breast cancer patients treated with tamoxifen. Journal of Pathology, 207(2), pp. 139-146. (doi: 10. 1002/path. 1829) VSports在线直播.

Tovey, S, Dunne, B, "V体育安卓版" Witton, CJ, Forsyth, A, Cooke, TG and Bartlett, JMS (2005) Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer. Clinical Cancer Research, 11, pp V体育2025版. 4835-4842. .

2004

Tovey, S.M., Witton, C.J., Bartlett, J.M.S., VSports - Stanton, P.D., Reeves, J.R. and Cooke, T.G. (2004) Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling. Breast Cancer Research, 6(3), R246-R251.